
Hung Q. Dang
Examiner (ID: 7761, Phone: (571)272-3069 , Office: P/2835 )
| Most Active Art Unit | 2484 |
| Art Unit(s) | 2635, 2484, 2612, 2621, 2835, 2841 |
| Total Applications | 2523 |
| Issued Applications | 1690 |
| Pending Applications | 218 |
| Abandoned Applications | 669 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19479369
[patent_doc_number] => 20240327411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => SIRT6 ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 18/471912
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18471912
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/471912 | SIRT6 ACTIVATORS | Sep 20, 2023 | Pending |
Array
(
[id] => 19389303
[patent_doc_number] => 20240279173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => Compounds and Methods for Inhibiting CYP26 Enzymes
[patent_app_type] => utility
[patent_app_number] => 18/367760
[patent_app_country] => US
[patent_app_date] => 2023-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18367760
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/367760 | Compounds and methods for inhibiting CYP26 enzymes | Sep 12, 2023 | Issued |
Array
(
[id] => 18980130
[patent_doc_number] => 11905290
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-20
[patent_title] => 5-substituted aminopyrimido[6',1':2,3]imidazo[4,5-c][1,6]naphthyridine compounds as CK2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/242152
[patent_app_country] => US
[patent_app_date] => 2023-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8959
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242152 | 5-substituted aminopyrimido[6',1':2,3]imidazo[4,5-c][1,6]naphthyridine compounds as CK2 inhibitors | Sep 4, 2023 | Issued |
Array
(
[id] => 19430868
[patent_doc_number] => 20240299366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/456718
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/456718 | IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | Aug 27, 2023 | Pending |
| 18/238425 | 2-(1-(2-HYDROXYPROPYL)-4,5-DIPHENYL-1H-IMIDAZOL-2-YL)PYRIDINE AS AN ANTICANCER COMPOUND | Aug 24, 2023 | Abandoned |
Array
(
[id] => 19049236
[patent_doc_number] => 20240091205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 18/361836
[patent_app_country] => US
[patent_app_date] => 2023-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361836
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361836 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE | Jul 28, 2023 | Pending |
Array
(
[id] => 19067168
[patent_doc_number] => 20240101594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => STEROIDS AND PROTEIN-CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/361275
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361275
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361275 | Steroids and protein-conjugates thereof | Jul 27, 2023 | Issued |
Array
(
[id] => 19257964
[patent_doc_number] => 12018005
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-06-25
[patent_title] => Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form
[patent_app_type] => utility
[patent_app_number] => 18/225925
[patent_app_country] => US
[patent_app_date] => 2023-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5294
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225925
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/225925 | Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form | Jul 24, 2023 | Issued |
Array
(
[id] => 18922911
[patent_doc_number] => 20240025915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => SOLID FORMS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL)-3,5-DIHYDRO-2H-PYRIDO[3,4-F][1,4]OXAZEPINE-9-CARBONITRILE
[patent_app_type] => utility
[patent_app_number] => 18/225236
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225236
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/225236 | SOLID FORMS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL)-3,5-DIHYDRO-2H-PYRIDO[3,4-F][1,4]OXAZEPINE-9-CARBONITRILE | Jul 23, 2023 | Abandoned |
Array
(
[id] => 19916141
[patent_doc_number] => 12291494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Methods of treating fibrosis
[patent_app_type] => utility
[patent_app_number] => 18/355790
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 28
[patent_no_of_words] => 8535
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18355790
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/355790 | Methods of treating fibrosis | Jul 19, 2023 | Issued |
Array
(
[id] => 18737866
[patent_doc_number] => 20230346766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION
[patent_app_type] => utility
[patent_app_number] => 18/350385
[patent_app_country] => US
[patent_app_date] => 2023-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350385
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/350385 | TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION | Jul 10, 2023 | Pending |
Array
(
[id] => 20479353
[patent_doc_number] => 12527816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
[patent_app_type] => utility
[patent_app_number] => 18/219444
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 5585
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18219444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/219444 | Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity | Jul 6, 2023 | Issued |
Array
(
[id] => 18837673
[patent_doc_number] => 11845734
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-19
[patent_title] => Selective 5-LO inhibitors for the treatment of bronchial asthma
[patent_app_type] => utility
[patent_app_number] => 18/215077
[patent_app_country] => US
[patent_app_date] => 2023-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7197
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215077
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/215077 | Selective 5-LO inhibitors for the treatment of bronchial asthma | Jun 26, 2023 | Issued |
Array
(
[id] => 18842558
[patent_doc_number] => 20230404962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => ANTIMICROBIAL, DISINFECTING AND WOUND HEALING COMPOSITIONS AND METHODS FOR PRODUCING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/339096
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339096
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/339096 | ANTIMICROBIAL, DISINFECTING AND WOUND HEALING COMPOSITIONS AND METHODS FOR PRODUCING AND USING SAME | Jun 20, 2023 | Pending |
Array
(
[id] => 19274417
[patent_doc_number] => 12024528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Bridged tricyclic carbamoylpyridone compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/334611
[patent_app_country] => US
[patent_app_date] => 2023-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75876
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/334611 | Bridged tricyclic carbamoylpyridone compounds and uses thereof | Jun 13, 2023 | Issued |
Array
(
[id] => 19447252
[patent_doc_number] => 20240307382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 18/330185
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 162211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18330185
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/330185 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Jun 5, 2023 | Pending |
Array
(
[id] => 18626602
[patent_doc_number] => 20230285396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHODS OF TREATING HEAVY MENSTRUAL BLEEDING
[patent_app_type] => utility
[patent_app_number] => 18/317725
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317725 | METHODS OF TREATING HEAVY MENSTRUAL BLEEDING | May 14, 2023 | Pending |
Array
(
[id] => 19081831
[patent_doc_number] => 20240108632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION AS OPHTHALMIC DROP TO PATIENT REQUIRING OPTIC NERVE PROTECTION
[patent_app_type] => utility
[patent_app_number] => 18/141086
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18141086
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/141086 | PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION AS OPHTHALMIC DROP TO PATIENT REQUIRING OPTIC NERVE PROTECTION | Apr 27, 2023 | Pending |
Array
(
[id] => 19921670
[patent_doc_number] => 12295929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Intravenous baclofen formulations and treatment methods
[patent_app_type] => utility
[patent_app_number] => 18/136777
[patent_app_country] => US
[patent_app_date] => 2023-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18136777
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/136777 | Intravenous baclofen formulations and treatment methods | Apr 18, 2023 | Issued |
Array
(
[id] => 18549993
[patent_doc_number] => 20230247991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ORGANIC ACID COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 18/298500
[patent_app_country] => US
[patent_app_date] => 2023-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298500
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/298500 | ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ORGANIC ACID COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME | Apr 10, 2023 | Pending |